iRhythm Holdings, Inc.

IRTC ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2017 FY2016 FY2015 FY2014
Revenue $99.1M $64.1M $36.1M $21.7M
Cost of Revenue $28.2M $20.9M $14.7M $10.6M
Gross Profit $70.9M $43.2M $21.4M $11.2M
Gross Margin 71.5% 67.4% 59.3% 51.3%
Operating Expenses
Research & Development $13.3M $7.2M $6.3M $5.7M
SG&A Expense $85.3M $51.6M $36.7M $20.2M
Operating Income $-27.6M $-15.6M $-21.6M $-14.8M
Operating Margin -27.8% -24.3% -59.9% -67.9%
Interest Expense $3.4M $3.2M $1.1M $774.0K
Pretax Income $-29.7M $-20.9M
Income Tax Expense $0 $0 $0 $0
Net Income $-29.7M $-20.9M $-22.8M $-15.8M
Net Margin -30.0% -32.6% -63.1% -72.8%
EPS (Basic) $-1.31 $-3.95 $-16.57 $-12.05
EPS (Diluted) $-1.31 $-3.95 $-16.57 $-12.05
Shares Outstanding (Basic) 23.4M 22.1M 1.4M
Shares Outstanding (Diluted) 23.4M 22.1M 1.4M
Dividends Per Share
← Newer Page 2 of 2 Older →